LYTIR

Company · INDV

Indivior Pharmaceuticals, Inc.

INDV is not in Nasdaq's symbol directory of securities listed on US exchanges.

In the 12 months to Nov 8, 2026: insiders bought on 2 occasions ($108K); insiders sold on 1 occasion ($765K); 2 filings by holders of 5% or more; 7 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $108K in total; Insider sales: $765K in total.Jul: Insider sales $765KAug: Insider purchases $108KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $108KInsider sales below: $765K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Heidbreder Christian, Chief Scientific Officer sold on 1 day all under a 10b5-1 plan latest Jul 10, 2026 sold $765K
  2. Anderson Woodrow D, Chief Accounting Officer bought on 2 days latest Aug 27, 2026 bought $108K
Every trade (3)
  1. BUYAnderson Woodrow D, Chief Accounting Officer bought Aug 27, 2026 1,500 shares filing $54K
  2. BUYAnderson Woodrow D, Chief Accounting Officer bought Aug 5, 2026 1,500 shares filing $54K
  3. SELLHeidbreder Christian, Chief Scientific Officer sold Jul 10, 2026 18,586 shares 10b5-1 plan (scheduled) filing $765K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Millennium Management LLC filed Sep 30, 2026 Schedule 13G passive filing 5.4%
  2. Oaktree Capital Holdings, LLC filed Aug 13, 2026 Schedule 13D/A may seek influence 385,037 shares filing 0.32%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Other events filing Nov 3, 2026
  2. Entry into a material definitive agreement; Completion of acquisition or disposition of assets; Creation of a direct financial obligation; Departure or appointment of directors or officers; Amendments to articles or bylaws; change in fiscal year; Regulation FD disclosure filing Nov 2, 2026
  3. Results of operations and financial condition filing Oct 29, 2026
  4. Submission of matters to a vote of security holders filing Oct 15, 2026
  5. Other events filing Oct 6, 2026
  6. Regulation FD disclosure; Other events filing Sep 17, 2026
  7. Termination of a material definitive agreement filing Sep 15, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.